A daily pill developed by the US pharmaceutical company Lilly may become a convenient alternative to injectable drugs like ...

DEAR PEOPLE’S PHARMACY: I’ve been on Ozempic for several months now. My blood sugar in the morning is around 103, down from ...

Prescribing of drugs between 2021 and 2023 shifted dramatically for both type 2 diabetes and weight loss for people with ...

Some experts say oral versions of popular weight-loss drugs such as Wegovy could offer people more flexibility and ...

Americans shelled out an estimated $71 billion for weight-loss drugs in 2023 - that is as much as the U.S. government disbursed in foreign aid the same year, according to ForeignAssistance.gov.

Federal law allows compounding pharmacies to make copies of name brand drugs while there’s a supply shortage. But there's a ...

If you're starting a semaglutide GLP-1 RA medication like Wegovy or Ozempic for weight loss, you may be wondering how soon ...

New research found hospital visits from Ozempic and Wegovy are rare, but can be serious. Experts explain the finding and ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

Independence Health Group, the parent company of Independence Blue Cross, spent $500 million last year to provide weight-control medications to its members.

People with type 2 diabetes taking the highest dose of Eli Lilly’s experimental drug orfoglipron lowered their blood sugar and lost 16 pounds on average after 40 weeks.

Initially developed to manage blood sugar levels in diabetic patients, GLP-1 agonists have gained popularity for their weight-reducing effects.